Mankind Pharma Limited (MANKIND.NS)
INR 2845.85
(1.42%)
INR 2845.85
(1.42%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 40.86 Billion INR | 50.37% |
| 2022 | 16.17 Billion INR | -15.88% |
| 2021 | 19.23 Billion INR | 15.48% |
| 2020 | 16.65 Billion INR | 10.02% |
| 2019 | 15.13 Billion INR | 74.12% |
| 2018 | 8.69 Billion INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 5.74 Billion INR | -1.19% |
| 2023 Q1 | 6.3 Billion INR | 89.91% |
| 2023 Q2 | 6.49 Billion INR | 2.98% |
| 2023 Q3 | 5.71 Billion INR | -12.02% |
| 2023 Q4 | 5.8 Billion INR | 1.65% |
| 2023 FY | 24.32 Billion INR | 50.37% |
| 2022 Q1 | 3.98 Billion INR | 59.99% |
| 2022 FY | 16.17 Billion INR | -15.88% |
| 2022 Q4 | 3.32 Billion INR | -14.9% |
| 2022 Q2 | 5.12 Billion INR | 28.61% |
| 2022 Q3 | 3.9 Billion INR | -23.78% |
| 2021 FY | 19.23 Billion INR | 15.48% |
| 2021 Q4 | 2.48 Billion INR | 0.0% |
| 2020 FY | 16.65 Billion INR | 10.02% |
| 2019 FY | 15.13 Billion INR | 74.12% |
| 2018 FY | 8.69 Billion INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Sigachi Industries Limited | 1.47 Billion INR | -2672.762% |
| Ind-Swift Limited | 1.22 Billion INR | -3233.509% |
| Bajaj HealthCare Limited | - INR | -Infinity% |
| Sakar Healthcare Limited | 495.5 Million INR | -8147.655% |
| Aurobindo Pharma Limited | 104.5 Billion INR | 60.894% |
| Innova Captab Limited | 2.53 Billion INR | -1513.147% |
| Divi's Laboratories Limited | 18.31 Billion INR | -123.198% |
| AstraZeneca Pharma India Limited | 4.47 Billion INR | -813.468% |
| Morepen Laboratories Limited | 4.17 Billion INR | -879.139% |
| Sequent Scientific Limited | - INR | -Infinity% |
| Wanbury Limited | 1.7 Billion INR | -2293.83% |
| Laurus Labs Limited | 3.94 Billion INR | -934.99% |
| Nectar Lifesciences Limited | 3.89 Billion INR | -950.422% |
| Glenmark Life Sciences Limited | 8.97 Billion INR | -355.137% |
| Alembic Limited | 767.77 Million INR | -5222.899% |
| Hikal Limited | 1.49 Billion INR | -2635.084% |
| Alembic Pharmaceuticals Limited | 5.75 Billion INR | -609.741% |
| Neuland Laboratories Limited | 5.31 Billion INR | -668.464% |
| J. B. Chemicals & Pharmaceuticals Limited | 7.54 Billion INR | -441.893% |
| Glenmark Pharmaceuticals Limited | 6.5 Billion INR | -528.503% |
| IOL Chemicals and Pharmaceuticals Limited | 4.94 Billion INR | -726.912% |
| Themis Medicare Limited | 1.3 Billion INR | -3036.173% |
| RPG Life Sciences Limited | 2.29 Billion INR | -1682.822% |
| Zydus Lifesciences Limited | 45.39 Billion INR | 9.967% |
| Lupin Limited | 27.75 Billion INR | -47.228% |
| Amrutanjan Health Care Limited | 621.02 Million INR | -6480.652% |
| Wockhardt Limited | 140 Million INR | -29091.161% |
| Vaishali Pharma Limited | 6.29 Million INR | -649210.852% |
| Aarti Pharmalabs Limited | 3.12 Billion INR | -1206.461% |
| Jagsonpal Pharmaceuticals Limited | 214.04 Million INR | -18993.452% |
| Jubilant Pharmova Limited | 5.18 Billion INR | -687.582% |
| FDC Limited | 3.03 Billion INR | -1247.104% |
| Dr. Reddy's Laboratories Limited | 67.72 Billion INR | 39.66% |
| Kilitch Drugs (India) Limited | 208.05 Million INR | -19543.175% |
| Eris Lifesciences Limited | 5.18 Billion INR | -688.688% |
| Venus Remedies Limited | 534.65 Million INR | -7543.795% |
| ZIM Laboratories Limited | 1.09 Billion INR | -3621.623% |
| Bliss GVS Pharma Limited | 1.23 Billion INR | -3219.869% |
| Par Drugs and Chemicals Limited | 551.58 Million INR | -7309.072% |
| Caplin Point Laboratories Limited | 7.22 Billion INR | -465.618% |
| Shilpa Medicare Limited | 3.76 Billion INR | -986.451% |
| Albert David Limited | 1.33 Billion INR | -2962.491% |
| Ajanta Pharma Limited | 19.67 Billion INR | -107.689% |
| Hester Biosciences Limited | 364.77 Million INR | -11103.669% |
| Suven Pharmaceuticals Limited | 4.6 Billion INR | -786.953% |
| Solara Active Pharma Sciences Limited | -3.85 Billion INR | 1160.698% |
| Gufic Biosciences Limited | 2.89 Billion INR | -1312.246% |
| Windlas Biotech Limited | 1.29 Billion INR | -3046.35% |
| Procter & Gamble Health Limited | 2.78 Billion INR | -1366.892% |
| Aarey Drugs & Pharmaceuticals Limited | 2.83 Million INR | -1443564.323% |
| Mangalam Drugs & Organics Limited | 27.45 Million INR | -148736.86% |
| Granules India Limited | 6.52 Billion INR | -526.011% |
| Aarti Drugs Limited | 7.14 Billion INR | -471.677% |
| Bal Pharma Limited | 214.56 Million INR | -18946.379% |
| Alkem Laboratories Limited | 19.46 Billion INR | -109.988% |
| Sun Pharmaceutical Industries Limited | 104.3 Billion INR | 60.819% |
| Lincoln Pharmaceuticals Limited | 1.9 Billion INR | -2043.788% |
| Medicamen Biotech Limited | - INR | -Infinity% |
| Unichem Laboratories Limited | - INR | -Infinity% |
| Bafna Pharmaceuticals Limited | 237.66 Million INR | -17095.764% |
| Biofil Chemicals and Pharmaceuticals Limited | 20.65 Million INR | -197748.688% |
| Valiant Laboratories Limited | - INR | -Infinity% |
| Orchid Pharma Limited | 2.36 Billion INR | -1630.888% |
| Medico Remedies Limited | 277.11 Million INR | -14647.373% |
| Ind-Swift Laboratories Limited | 2 Billion INR | -1934.194% |
| Ipca Laboratories Limited | 29.59 Billion INR | -38.083% |
| Brooks Laboratories Limited | -72.25 Million INR | 56662.621% |
| Syncom Formulations (India) Limited | 249.25 Million INR | -16296.173% |
| Piramal Enterprises Limited | - INR | -Infinity% |
| Torrent Pharmaceuticals Limited | 25.33 Billion INR | -61.308% |
| NATCO Pharma Limited | 25.96 Billion INR | -57.413% |
| Suven Life Sciences Limited | -1.22 Billion INR | 3433.896% |
| Krebs Biochemicals & Industries Limited | - INR | -Infinity% |
| Strides Pharma Science Limited | 5.22 Billion INR | -682.034% |
| Indoco Remedies Limited | 1.52 Billion INR | -2580.899% |
| Alpa Laboratories Limited | 61.51 Million INR | -66335.219% |
| Lasa Supergenerics Limited | -458 Million INR | 9022.965% |
| Sun Pharma Advanced Research Company Limited | -4.11 Billion INR | 1093.128% |